Literature DB >> 34986330

Why does obesity cause diabetes?

Samuel Klein1, Amalia Gastaldelli2, Hannele Yki-Järvinen3, Philipp E Scherer4.   

Abstract

The accumulation of an excessive amount of body fat can cause type 2 diabetes, and the risk of type 2 diabetes increases linearly with an increase in body mass index. Accordingly, the worldwide increase in the prevalence of obesity has led to a concomitant increase in the prevalence of type 2 diabetes. The cellular and physiological mechanisms responsible for the link between obesity and type 2 diabetes are complex and involve adiposity-induced alterations in β cell function, adipose tissue biology, and multi-organ insulin resistance, which are often ameliorated and can even be normalized with adequate weight loss.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34986330      PMCID: PMC8740746          DOI: 10.1016/j.cmet.2021.12.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  110 in total

1.  Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.

Authors:  Elisa Fabbrini; Robyn A Tamboli; Faidon Magkos; Pamela A Marks-Shulman; Aaron W Eckhauser; William O Richards; Samuel Klein; Naji N Abumrad
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

Review 2.  The many secret lives of adipocytes: implications for diabetes.

Authors:  Philipp E Scherer
Journal:  Diabetologia       Date:  2018-11-21       Impact factor: 10.122

3.  Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle.

Authors:  A Virkamäki; E Korsheninnikova; A Seppälä-Lindroos; S Vehkavaara; T Goto; J Halavaara; A M Häkkinen; H Yki-Järvinen
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

Review 4.  Reduced early insulin secretion in the etiology of type 2 diabetes mellitus in Pima Indians.

Authors:  Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

6.  Relation of body fat distribution to metabolic complications of obesity.

Authors:  A H Kissebah; N Vydelingum; R Murray; D J Evans; A J Hartz; R K Kalkhoff; P W Adams
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

Review 7.  Metabolic Messengers: Adiponectin.

Authors:  Leon G Straub; Philipp E Scherer
Journal:  Nat Metab       Date:  2019-03-14

Review 8.  Fatty acids, obesity, and insulin resistance: time for a reevaluation.

Authors:  Fredrik Karpe; Julian R Dickmann; Keith N Frayn
Journal:  Diabetes       Date:  2011-10       Impact factor: 9.461

9.  Adipose-derived circulating miRNAs regulate gene expression in other tissues.

Authors:  Thomas Thomou; Marcelo A Mori; Jonathan M Dreyfuss; Masahiro Konishi; Masaji Sakaguchi; Christian Wolfrum; Tata Nageswara Rao; Jonathon N Winnay; Ruben Garcia-Martin; Steven K Grinspoon; Phillip Gorden; C Ronald Kahn
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

10.  Suppressing adipocyte inflammation promotes insulin resistance in mice.

Authors:  Qingzhang Zhu; Yu A An; Min Kim; Zhuzhen Zhang; Shangang Zhao; Yi Zhu; Ingrid Wernstedt Asterholm; Christine M Kusminski; Philipp E Scherer
Journal:  Mol Metab       Date:  2020-05-11       Impact factor: 7.422

View more
  18 in total

1.  Do lifestyle factors and quality of life differ in people with metabolically healthy and unhealthy obesity?

Authors:  Sarah S Farabi; Gordon I Smith; George G Schweitzer; Richard I Stein; Samuel Klein
Journal:  Int J Obes (Lond)       Date:  2022-07-11       Impact factor: 5.551

Review 2.  Cardiovascular Disease Risk Reduction and Body Mass Index.

Authors:  Rohan Samson; Pierre Vladimir Ennezat; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2022-07-05       Impact factor: 4.592

Review 3.  Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target.

Authors:  Akilavalli Narasimhan; Rafael R Flores; Christina D Camell; David A Bernlohr; Paul D Robbins; Laura J Niedernhofer
Journal:  Curr Diab Rep       Date:  2022-10-14       Impact factor: 5.430

4.  Waist circumference and dysglycaemia: new insights and additional questions, but do not miss the opportunity to measure it!

Authors:  Caterina Conte
Journal:  Intern Emerg Med       Date:  2022-08-30       Impact factor: 5.472

Review 5.  GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

Authors:  Maurício Reis Pedrosa; Denise Reis Franco; Hannah Waisberg Gieremek; Camila Maia Vidal; Fernanda Bronzeri; Alexia de Cassia Rocha; Luis Gabriel de Carvalho Cara; Sofia Lenzi Fogo; Freddy Goldberg Eliaschewitz
Journal:  Curr Atheroscler Rep       Date:  2022-08-31       Impact factor: 5.967

Review 6.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 7.  Role of Innate lymphoid Cells in Obesity and Insulin Resistance.

Authors:  Hong Chen; Lijun Sun; Lu Feng; Yue Yin; Weizhen Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-27       Impact factor: 6.055

8.  Personalised Nutritional Recommendations Based on Individual Post-Prandial Glycaemic Responses Improve Glycaemic Metrics and PROMs in Patients with Type 2 Diabetes: A Real-World Assessment.

Authors:  Madlen Ungersboeck; Xiaowen Tang; Vanessa Neeff; Dominic Steele; Pascal Grimm; Matthew Fenech
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

9.  Multitarget Action of Xanthones from Garcinia mangostana against α-Amylase, α-Glucosidase and Pancreatic Lipase.

Authors:  Juan Cardozo-Muñoz; Luis E Cuca-Suárez; Juliet A Prieto-Rodríguez; Fabian Lopez-Vallejo; Oscar J Patiño-Ladino
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

10.  Diagnostic and Prognostic Protein Biomarkers of β-Cell Function in Type 2 Diabetes and Their Modulation with Glucose Normalization.

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Metabolites       Date:  2022-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.